| An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi Breast cancer research and treatment 123, 725-731, 2010 | 2887 | 2010 |
| Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer B Győrffy, P Surowiak, J Budczies, A Lánczky PloS one 8 (12), e82241, 2013 | 1734 | 2013 |
| Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8 (1), 9227, 2018 | 1251 | 2018 |
| Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization J Budczies, F Klauschen, BV Sinn, B Győrffy, WD Schmitt, ... PloS one 7 (12), e51862, 2012 | 1172 | 2012 |
| Web-based survival analysis tool tailored for medical research (KMplot): development and implementation A Lánczky, B Győrffy Journal of medical Internet research 23 (7), e27633, 2021 | 1077 | 2021 |
| Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ... Oncotarget 7 (31), 49322, 2016 | 931 | 2016 |
| Pancancer survival analysis of cancer hallmark genes Á Nagy, G Munkácsy, B Győrffy Scientific reports 11 (1), 6047, 2021 | 899 | 2021 |
| Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. B Győrffy, A Lánczky, Z Szállási Endocrine-related cancer 19 (2), 197-208, 2012 | 869 | 2012 |
| miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy Breast cancer research and treatment 160, 439-446, 2016 | 746 | 2016 |
| Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer B Győrffy Computational and structural biotechnology journal 19, 4101-4109, 2021 | 699 | 2021 |
| TNMplot. com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues Á Bartha, B Győrffy International journal of molecular sciences 22 (5), 2622, 2021 | 550 | 2021 |
| Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma O Menyhárt, Á Nagy, B Győrffy Royal Society open science 5 (12), 181006, 2018 | 370 | 2018 |
| Jetset: selecting the optimal microarray probe set to represent a gene Q Li, NJ Birkbak, B Gyorffy, Z Szallasi, AC Eklund BMC bioinformatics 12, 1-7, 2011 | 338 | 2011 |
| Multigene prognostic tests in breast cancer: past, present, future B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai Breast cancer research 17 (1), 11, 2015 | 316 | 2015 |
| Multigene prognostic tests in breast cancer: past, present, future B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai Breast cancer research 17 (1), 11, 2015 | 316 | 2015 |
| Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla–Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast … Á Sávolt, G Péley, C Polgár, N Udvarhelyi, G Rubovszky, E Kovács, ... European Journal of Surgical Oncology (EJSO) 43 (4), 672-679, 2017 | 277 | 2017 |
| Pancancer survival analysis of cancer hallmark genes. bioRxiv A Nagy, G Munkacsy, B Gyorffy Probe ID: 206571_s_at p-value 3, 2020 | 247 | 2020 |
| ROCplot. org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients JT Fekete, B Győrffy International journal of cancer 145 (11), 3140-3151, 2019 | 243 | 2019 |
| Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities DC Porter, E Farmaki, S Altilia, GP Schools, DK West, M Chen, BD Chang, ... Proceedings of the National Academy of Sciences 109 (34), 13799-13804, 2012 | 215 | 2012 |
| Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations B Györffy, P Surowiak, O Kiesslich, C Denkert, R Schäfer, M Dietel, ... International journal of cancer 118 (7), 1699-1712, 2006 | 209 | 2006 |
Jan BudcziesProfessor of Bioinformatics, Institute of Pathology, University Hospital Heidelberg在 med.uni-heidelberg.de 的电子邮件经过验证
